Price Chart: Enlivex Therapeutics (ENLV)

Symbol and logo of brand Enlivex Therapeutics Ltd (ENLV)

The potential of Enlivex Therapeutics (ENLV) is based on immune system research, however, the lack of stable cash flow makes the company dependent on external financing, which currently stands at 1.11. Operational flexibility is achieved through the full outsourcing of production and testing. The price action history below illustrates the commercialization prospects of Allocetra, an innovative method for combating sepsis via cell reprogramming.

Price Chart: Enlivex Therapeutics Ltd. (ENLV) for 07/04/2022 - 11/17/2026

Enlivex Therapeutics - analytical breakdowns and key metrics (ENLV)

- company stock exchange capitalization indicators:
Fundamental valuation:Enlivex Therapeutics Ltd
Signature product of Enlivex Therapeutics, Ltd.

Identifying a fundamental floor for Enlivex Therapeutics (ENLV) requires an analysis of the market consensus, where trading dynamics visualize the aggregate valuation of sepsis cell therapy prospects. Since the uniqueness of the immune reprogramming method provides the company with exceptional pricing power, this chart reflects future capitalization of technological leadership rather than current expenditures, turning the share price into an indicator of the business's strategic value.

Analysis of competing companies

Stock Price ARGX|Price Chart BNTX (BioNTech Inc.)|Stock Price ABVX (Abivax S.A.)|ADMA: Share Price|Protagonist Corp - Stock Price|IMVT: Price Chart|KNSA: Stock Price|GRFS - Market Chart|Price Chart Adaptive Biotechnologies Corporation|Celldex - Quote Chart|Stock Price AUPH|BCRX (BioCryst) - Price Performance Chart|Stock Price VERA (veratx.com)|Stock Price Dianthus Therapeutics Inc DNTH|PHVS - Price Chart|Price Performance Chart ABCL (AbCellera Biologics Inc.)|tourmalinebio.com (TRML) - Price Chart|Stock Quotes Precigen, Inc.|PHAR (pharming.com) - Stock Price|Stock Price Nektar|Stock Price UPB|ZBIO (Zenas Biopharma, Inc.) - Price Performance Chart|Stock Price IMNM (immunome.com)|Market Chart gossamerbio.com (GOSS)|KALV - Price Chart|Septerna, Inc. (SEPN) - Stock Quotes|Pieris Corp (PVLA) - Price Chart|Stock Quotes Savara Inc.|Stock Quotes RIGL|Stock Price anaptysbio.com|Price Chart Astria Pharma (ATXS)|enGene - Share Price|Stock Price RAPT (rapt.com)|Aerovate (JBIO) - Market Price|Aclaris Therapeutics, Inc - Stock Price|KYTX - Stock Price|TLSA: Stock Price|Cabaletta Bio (CABA) - Stock Price|Price Chart Ventyx Biosciences|Market Price Theratechnologies, Inc THTX|Price Chart Avalo Therapeutics, Inc (AVTX)|eledon.com - Share Price|agenusbio.com - Stock Quotes|Climb Bio, Inc. - Price Chart|Zura Bio - Stock Price|Quote Chart ATYR|ADAG: Stock Price|IMA (ImageneBio) - Price Chart|Price Chart Shattuck Therapeutics|EQ: Price Performance Chart|Stock Price CNTB|Market Chart Immunic Therapeutics|Atara Bio - Stock Quotes|Market Chart inflarx.de (IFRX)|XFOR (X4 Pharmaceuticals Inc.) - Market Price|ACET - Stock Price|CELU: Stock Price|INMB - Market Chart|Price Chart Barinthus Biotherapeutics PLC|Kezar Life Sciences (KZR) - Market Chart|Stock Price SABS|Stock Price Akari Therapeutics plc (AKTX)|Stock Price QTTB (Q32 Bio Corp)|GOVX - Stock Quotes|EDSA - Price Chart|IBIO - Stock Price|CARM (carismatx.com) - Stock Quotes|XTLB: Price|BOLT (Bolt Biotherapeutics, Inc.) - Stock Price|HCW Biologics Inc. (HCWB) - Market Chart|Price Chart Aptevo (APVO)|Stock Price aimimmuno.com (AIM)|Price Chart Aditxt ADTX|Stock Price GRI Bio Corp GRI|XRTX - Price Chart|HIND (ReShape Lifesciences) - Share Price|revbiosciences.com (REVB) - Price Chart|INDP - Market Chart|SCNI (Scinai Immunotherapeutics Ltd) - Stock Price|Stock Price calcimedica.com|Stock Price AFMD|Market Chart Allakos Inc|Stock Price HOOK (HOOKIPA Pharma Inc.)|IGMS (IGM Bio) - Quote Chart|ITOS - Price Chart|Quote Chart OCEA|TC Biopharm (TCBP) - Price Chart|Stock Quotes Third Harmonic Bio, Inc